Category: Life Sciences
Global Life Sciences
-
Microwave Ablation
... CAGR of 13.2% over the analysis period 2024-2030. Liver Cancer, one of the segments analyzed in the report, is expected to record a 15.2% CAGR and reach US$215.5 Million by the end of the analysis ... Read More
-
Vancomycin
... 4.9% over the analysis period 2024-2030. Lung Infection, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$201.9 Million by the end of the analysis period. Growth ... Read More
-
Venturi Masks
... CAGR of 11.5% over the analysis period 2024-2030. COPD, one of the segments analyzed in the report, is expected to record a 13.5% CAGR and reach US$2.9 Billion by the end of the analysis period. ... Read More
-
Allografts
... 6.9% over the analysis period 2024-2030. Demineralized Bone Matrix (DBM), one of the segments analyzed in the report, is expected to record a 7.3% CAGR and reach US$488.4 Million by the end of the analysis ... Read More
-
Narcolepsy Therapeutics
... CAGR of 7.1% over the analysis period 2024-2030. Narcolepsy with Cataplexy, one of the segments analyzed in the report, is expected to record a 6.8% CAGR and reach US$1.9 Billion by the end of the ... Read More
-
Molecular Cytogenetics
... CAGR of 8.8% over the analysis period 2024-2030. Consumables, one of the segments analyzed in the report, is expected to record a 8.9% CAGR and reach US$2.0 Billion by the end of the analysis period. ... Read More
-
Biofuel Enzymes
... CAGR of 6.7% over the analysis period 2024-2030. Amylase Enzymes, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$726.4 Million by the end of the analysis ... Read More
-
Biophotonics
... 10.8% over the analysis period 2024-2030. See-through Imaging, one of the segments analyzed in the report, is expected to record a -1.6% CAGR and reach US$34.1 Billion by the end of the analysis period. Growth ... Read More
-
Direct-to-Consumer (DTC) Genetic Testing
... 2030, growing at a CAGR of 14.0% over the analysis period 2024-2030. Single Nucleotide Polymorphism (SNP) Chips, one of the segments analyzed in the report, is expected to record a 13.6% CAGR and reach US$1.6 ... Read More
-
Ion Channel Modulators
... at a CAGR of 3.5% over the analysis period 2024-2030. Channel Blockers, one of the segments analyzed in the report, is expected to record a 3.8% CAGR and reach US$12.4 Billion by the end of ... Read More
-
Clinical Laboratory Services
... at a CAGR of 5.3% over the analysis period 2024-2030. Clinical Chemistry, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$163.3 Billion by the end of ... Read More
-
Metabolomics
... 11.7% over the analysis period 2024-2030. Biomarker Discovery Application, one of the segments analyzed in the report, is expected to record a 13.0% CAGR and reach US$3.3 Billion by the end of the analysis period. ... Read More
-
Full Body Scanners
... at a CAGR of 11.3% over the analysis period 2024-2030. Millimeter, one of the segments analyzed in the report, is expected to record a 11.7% CAGR and reach US$609.0 Million by the end of the ... Read More
-
Parenteral Nutrition
... CAGR of 6.8% over the analysis period 2024-2030. Single Dose Amino Acid Solution, one of the segments analyzed in the report, is expected to record a 7.1% CAGR and reach US$4.1 Billion by the end ... Read More
-
Intracranial Stents
... CAGR of 12.9% over the analysis period 2024-2030. Self-Expanding Stents, one of the segments analyzed in the report, is expected to record a 13.9% CAGR and reach US$594.0 Million by the end of the analysis ... Read More
-
Orthodontic Supplies
... CAGR of 8.4% over the analysis period 2024-2030. Fixed Braces, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$4.5 Billion by the end of the analysis ... Read More
-
Dental Preventive Supplies
... at a CAGR of 4.3% over the analysis period 2024-2030. The U.S. Market is Estimated at US$156.3 Million While China is Forecast to Grow at 6.4% CAGR The Dental Preventive Supplies market in the U.S. ... Read More
-
Analytical Standards
... CAGR of 6.6% over the analysis period 2024-2030. Pharmaceutical & Life Science Analysis Application, one of the segments analyzed in the report, is expected to record a 7.4% CAGR and reach US$611.4 Million by the ... Read More
-
Automated Storage and Retrieval Systems (ASRS)
... reach US$13.4 Billion by 2030, growing at a CAGR of 7.1% over the analysis period 2024-2030. Unit Load, one of the segments analyzed in the report, is expected to record a 6.6% CAGR and reach ... Read More
-
Automotive Upholstery
... CAGR of 7.6% over the analysis period 2024-2030. Seat Cover, one of the segments analyzed in the report, is expected to record a 9.0% CAGR and reach US$2.7 Billion by the end of the analysis ... Read More
-
Clinical Communication and Collaboration
... 2030, growing at a CAGR of 11.8% over the analysis period 2024-2030. Solutions, one of the segments analyzed in the report, is expected to record a 11.4% CAGR and reach US$3.2 Billion by the end ... Read More
-
Continuous Renal Replacement Therapy (CRRT)
... Billion by 2030, growing at a CAGR of 5.9% over the analysis period 2024-2030. Dialysates & Replacement Fluids, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach ... Read More
-
Contrast Media
... CAGR of 3.2% over the analysis period 2024-2030. Barium-based Contrast Media, one of the segments analyzed in the report, is expected to record a 2.1% CAGR and reach US$305.4 Million by the end of the ... Read More
-
Dental Practice Management Software
... 2030, growing at a CAGR of 9.3% over the analysis period 2024-2030. Web-based, one of the segments analyzed in the report, is expected to record a 8.4% CAGR and reach US$1.7 Billion by the end ... Read More
-
Diagnostic Imaging
... CAGR of 5.1% over the analysis period 2024-2030. X-ray Imaging, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$9.4 Billion by the end of the analysis ... Read More
Research Assistance
